Published December 30, 2021
| Version v1
Journal article
Open
Alzheimer's disease and Aβ pathways
Authors/Creators
- 1. Department of Neurology & Rehabilitation Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.
- 2. Department of Biotechnology, Manipur University, Chanchipur, Imphal-795003, India.
Description
Alzheimer's disease (AD) is a neurodegenerative disease which is one of the major health issues globally. It is the 6th cause of death in the United States. Approximately, 60–70% of cases of dementia are caused by AD. The disease advances with age worsening the symptoms that include problems with declining memory, language, mood swings, loss of motivation, self-neglect, and other behavioral issues. AD patients need a long-term health care and hospital services as the disease worsens with the advancing of their age. However, proper medications and treatment is still unavailable as the cause of AD is poorly understood.